Several groups whose members include 340B hospitals yesterday slammed the Biden administration’s proposal to continue the Trump administration’s huge cut in Medicare Part B reimbursement for hospitals’ 340B purchased drugs.
The new administration yesterday announced its proposed plans for payments to hospitals for 340B-purchased drugs in its hospital outpatient prospective payment system (OPPS) proposed rule for 2022. Comments on the proposed OPPS rule are due Sept. 17.
Several groups whose members or clients include 340B hospitals yesterday slammed the Biden administration’s decision to continue the Trump administration’s huge cut in Medicare Part B reimbursement for hospitals’ 340B purchased drugs. The American Hospital Association (AHA) has not, so far.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
